Enhanced angiogenesis with multimodal cell-based gene therapy.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Annals of Thoracic Surgery

• Publication date

  2007-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.ATHORACSUR.2006.10.050PMID 17307468
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of cell-based angiogenic gene therapy at 6 months: persistent angiogenesis and absence of oncogenicity.

  2007cited by this paper
• Enhanced angiogenesis with multimodal cell-based gene therapy.

  2007cited by this paper
• From Gene Therapy and Stem Cells to Clinical Electrophysiology

  2006cited by this paper
• Vascular endothelial growth factor receptor upregulation in response to cell-based angiogenic gene therapy.

  2005cited by this paper
• Paracrine action enhances the effects of autologous mesenchymal stem cell transplantation on vascular regeneration in rat model of myocardial infarction.

  2005cited by this paper
• Maximizing Ventricular Function With Multimodal Cell-Based Gene Therapy

  2005cited by this paper
• Increasing transplanted cell survival with cell-based angiogenic gene therapy.

  2005cited by this paper
• Enhanced IGF-1 expression improves smooth muscle cell engraftment after cell transplantation.

  2004cited by this paper
• Angiogenic pretreatment improves the efficacy of cellular cardiomyoplasty performed with fetal cardiomyocyte implantation.

  2004cited by this paper
• Vascular endothelial growth factor transgene expression in cell-transplanted hearts.

  2004cited by this paper
• Gene therapy in cardiac surgery: is there a role?

  2003cited by this paper
• Improved therapeutic efficacy in cardiomyocyte transplantation for myocardial infarction with release system of basic fibroblast growth factor.

  2003cited by this paper
• Vascular growth factors and angiogenesis in cardiac surgery.

  2003cited by this paper
• Beneficial effect of autologous cell transplantation on infarcted heart function: comparison between bone marrow stromal cells and heart cells.

  2003cited by this paper
• Prevascularization with gelatin microspheres containing basic fibroblast growth factor enhances the benefits of cardiomyocyte transplantation.

  2002cited by this paper
• Enhanced Myocardial Angiogenesis by Gene Transfer With Transplanted Cells

  2001cited by this paper
• Efficacy of intracoronary or intravenous VEGF165 in a pig model of chronic myocardial ischemia.

  2001cited by this paper
• VEGF gene delivery to myocardium: deleterious effects of unregulated expression.

  2000cited by this paper
• Efficacy of intracoronary versus intravenous FGF-2 in a pig model of chronic myocardial ischemia.

  2000cited by this paper
• Overexpression of VEGF 121 in immortalized endothelial cells causes conversion to slowly growing angiosarcoma and high level expression of the VEGF receptors VEGFR-1 and VEGFR-2 in vivo.

  2000cited by this paper
• Autologous transplantation of bone marrow cells improves damaged heart function.

  1999cited by this paper
• Vascular endothelial growth factor increases the mitogenic response to fibroblast growth factor-2 in vascular smooth muscle cells in vivo via expression of fms-like tyrosine kinase-1.

  1997cited by this paper
• Vascular endothelial growth factor-induced in vitro angiogenesis and plasminogen activator expression are dependent on endogenous basic fibroblast growth factor.

  1997cited by this paper
• Basic fibroblast growth factor upregulates the expression of vascular endothelial growth factor in vascular smooth muscle cells. Synergistic interaction with hypoxia.

  1995cited by this paper
• Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels.

  1993cited by this paper
• Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms.

  1989cited by this paper
• Recommendations Regarding Quantitation in M-Mode Echocardiography: Results of a Survey of Echocardiographic Measurements

  1978cited by this paper

• Biophysical and Biochemical Cues of Biomaterials Guide Mesenchymal Stem Cell Behaviors

  2021influential citation
• Stem Cell-Mediated Angiogenesis in Tissue Engineering Constructs.

  2019cites this paper
• Polymeric Scaffold Based Gene Delivery Strategies to Improve Angiogenesis in Tissue Engineering: A Review

  2017cites this paper
• Cell therapies: The next-generation clinical trials.

  2017cites this paper
• Impact of Cellular Mechanisms of Ischemia on CABG Failure

  2016cites this paper
• MicroRNAs with Mega Functions in Cardiac Remodeling and Repair: The Micromanagement of Matters of the Heart

  2015cites this paper
• How Regenerative Medicine Can Benefit from Nucleic Acids Delivery Nanocarriers

  2015cites this paper
• Heart regeneration with engineered myocardial tissue.

  2014cites this paper
• Transmyocardial Revascularization Enhances Bone Marrow Stem Cell Engraftment in Infarcted Hearts Through SCF—C-kit and SDF-1—CXCR4 Signaling Axes

  2014cites this paper
• The promise and challenges of cardiac stem cell therapy.

  2014cites this paper
• Transmyocardial Revascularization Enhances Mesenchymal Stem Cell Engraftment in Infarcted Hearts through SCF–c-Kit and SDF-1–CXCR4 Signaling Axes

  2013cites this paper
• Gene doping: an overview and current implications for athletes

  2013cites this paper
• Mesenchymal Stem Cell Transplantation Mitigates Electrophysiological Remodeling in a Rat Model of Myocardial Infarction

  2013cites this paper
• Cytoprotective and Proangiogenic Activity of Ex-Vivo Netrin-1 Transgene Overexpression Protects the Heart Against Ischemia/Reperfusion Injury

  2012cites this paper
• Topical Negative Pressure, Applied onto the Myocardium, a Potential Alternative Treatment for Patients with Coronary Artery Disease in the Future

  2012cites this paper
• Nonviral delivery of genetic medicine for therapeutic angiogenesis.

  2012influential citation
• Inhibiting Matrix Metalloproteinase by Cell-Based Timp-3 Gene Transfer Effectively Treats Acute and Chronic Ischemic Cardiomyopathy

  2012cites this paper
• Therapeutic angiogenesis using genetically engineered human endothelial cells.

  2012cites this paper
• Zelltherapie nach akutem Myokardinfarkt Untersuchungen der funktionellen und sympathoadrenergen Veränderungen im Langzeit in-vivo Kleintiermodell

  2011cites this paper
• Transforming growth factor-α enhances stem cell-mediated postischemic myocardial protection.

  2011cites this paper
• Gene therapy for ischemic heart disease.

  2011cites this paper
• Angiopoietin-1 for Myocardial Angiogenesis

  2011cites this paper
• Mesenchymal Stem Cells Overexpressing Ephrin-B2 Rapidly Adopt an Early Endothelial Phenotype with Simultaneous Reduction of Osteogenic Potential

  2010cites this paper
• De Novo Myocardial Regeneration: Advances and Pitfalls

  2010cites this paper
• NV1FGF, a pCOR plasmid-based angiogenic gene therapy for the treatment of intermittent claudication and critical limb ischemia.

  2009cites this paper
• Angiomyogenesis for Myocardial Repair

  2009influential citation
• Cell-based gene therapy modifies matrix remodeling after a myocardial infarction in tissue inhibitor of matrix metalloproteinase-3-deficient mice.

  2009cites this paper
• Tissue Engineering Applications for Cardiovascular Substitutes

  2009cites this paper
• Tracking cardiac engraftment and distribution of implanted bone marrow cells: Comparing intra-aortic, intravenous, and intramyocardial delivery.

  2009cites this paper
• Myocardial Topical Negative Pressure

  2008cites this paper
• Topical negative pressure effects on coronary blood flow in a sternal wound model

  2008cites this paper
• Effect of mouse VEGF164 on the viability of hydroxyethyl methacrylate-methyl methacrylate-microencapsulated cells in vivo: bioluminescence imaging.

  2008cites this paper
• Locally overexpressing hepatocyte growth factor prevents post-ischemic heart failure by inhibition of apoptosis via calcineurin-mediated pathway and angiogenesis.

  2008cites this paper
• Paracrine effects of cell transplantation: modifying ventricular remodeling in the failing heart.

  2008cites this paper
• Paracrine effects of cell transplantation: strategies to augment the efficacy of cell therapies.

  2008cites this paper
• Cell Transplantation Therapy for Myocardial Repair: Current Status and Future Challenges

  2008cites this paper
• Invited commentary.

  2007cites this paper
• Bone marrow cell-mediated cardiovascular repair: potential of combined therapies.

  2007cites this paper
• Therapeutic approaches in vascular repair induced by adult bone marrow cells and circulating progenitor endothelial cells.

  2007cites this paper
• No hypoperfusion is produced in the epicardium during application of myocardial topical negative pressure in a porcine model

  2007cites this paper
• Combined transmyocardial revascularization and cell-based angiogenic gene therapy increases transplanted cell survival.

  2007cites this paper
• Enhanced angiogenesis with multimodal cell-based gene therapy.

  2007cites this paper